Results 71 to 80 of about 1,816,514 (190)

Thrombus‐Induced Prosthetic Valve Dysfunction Demonstrating Hypo‐Attenuated Leaflet Thickening: A Case Report

Clinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT Hypo‐attenuated leaflet thickening (HALT) is an important and potentially underrecognized cause of late bioprosthetic valve dysfunction after surgical AVR. Multimodal imaging, including echocardiography and electrocardiogram‐gated computed tomography, is essential for diagnosis, and timely surgical or medical intervention can effectively ...
Takanori Kono, Kazuyoshi Takagi, Yusuke Shintani, Hiroki Mine, Eiki Tayama   +4 more
wiley   +1 more source

Advancements in transcatheter tricuspid valve repair and replacement: a state-of-the-art review with echocardiographic outcomes

Global Cardiology
Tricuspid regurgitation (TR) affects over 1.6 million individuals in the United States, with a one-year mortality rate of 36.1% and a five-year survival below 30%.
Asad Gul Rao, Syed Sarmad Javaid, Ahmed Mustafa Rashid, Fawaz Alenezi   +3 more
doaj   +1 more source

Cerebrovascular Events in Aortic Stenosis: From Native Valve Disease to TAVR‐Specific Risk and Prevention

Catheterization and Cardiovascular Interventions, Volume 108, Issue 2, Page 331-342, August 1, 2026.
ABSTRACT Aortic stenosis (AS) is associated with a heightened burden of cardiovascular comorbidities, atrial fibrillation (AF), and progressive valvular calcification, all of which may contribute to cerebrovascular events across the disease continuum.
Priyanka Boettger, Jamschid Sedighi, Martin Juenemann, Omar Alhaj‐Omar, Kerstin Piayda, Mani Arsalan, Samuel Sossalla, Won‐Keun Kim   +7 more
wiley   +1 more source

Transcatheter Tricuspid Valve Clinical Trials: Incomplete Data and FDA-Approved Devices

Structural Heart
Each reviewed trial of transcatheter tricuspid valve intervention demonstrated clinically meaningful improvement in Kansas City Cardiomyopathy Questionnaire (KCCQ)-defined quality of life and favorable right ventricular remodeling.
Deborah Furman, MD, Brian Whisenant, MD
doaj   +1 more source

Nine‐Year Follow‐Up After M‐TEER for Secondary Mitral Regurgitation in a Patient With Cardiogenic Shock

Catheterization and Cardiovascular Interventions, Volume 108, Issue 2, Page 483-488, August 1, 2026.
ABSTRACT Background Transcatheter edge‐to‐edge repair (TEER) has become an established therapeutic option for patients with severe secondary mitral regurgitation (SMR). While randomized trials and registry data have reported outcomes up to 5 years, longer follow‐up data remain scarce.
Tobias Reithmayer, Thomas J. Stocker, Ludwig T. Weckbach, Julia Novotny, Philipp M. Doldi, Hannah Kempton, Steffen Massberg, Michael Näbauer, Jörg Hausleiter, Lukas Stolz   +9 more
wiley   +1 more source

Transcatheter treatment of the tricuspid valve: current status and perspectives. [PDF]

Transcatheter tricuspid valve interventions (TTVI) are emerging as alternatives to surgery in high-risk patients with isolated or concomitant tricuspid regurgitation.
Maisano, Francesco, Lurz, Philipp, Praz, Fabien, Sorajja, Paul, Hahn, Rebecca   +4 more
core   +1 more source

Impella‐Assisted High‐Risk Percutaneous Coronary Intervention in Cardiogenic Shock With Low‐Flow, Low‐Gradient Aortic Stenosis and Multivessel Coronary Artery Disease: A Case Report

Clinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT Patients with cardiogenic shock, low‐flow, low‐gradient aortic stenosis, and multivessel coronary artery disease who are ineligible for surgery present a major therapeutic challenge. Percutaneous mechanical circulatory support may facilitate revascularization in this high‐risk population. A 69‐year‐old man presented after a mechanical fall and
Douni Roger, Waleed Shaker, Zan Siddiqi, George Abela   +3 more
wiley   +1 more source

Transcatheter tricuspid valve replacement: will it prevail?

Frontiers in Cardiovascular Medicine
Severe tricuspid regurgitation (TR) is a prevalent and challenging condition associated with poor survival outcomes and significant morbidity. Medical therapy alone often fails to provide adequate symptom relief, and stand-alone surgical intervention is ...
Xiling Zhang, Xiling Zhang, Nina Sophie Pommert, Nina Sophie Pommert, David Meier, Stephanie L. Sellers, Stephanie L. Sellers, Stephanie L. Sellers, Hatim Seoudy, Hatim Seoudy, Oliver J. Müller, Oliver J. Müller, Derk Frank, Derk Frank, Tim Attmann, Tim Attmann, Rouven Berndt, Gregor Warnecke, Gregor Warnecke, Thomas Puehler, Thomas Puehler, Georg Lutter, Georg Lutter   +22 more
doaj   +1 more source

Association Between Inferior Vena Cava Location and the Number of Deployments of a Leadless Pacemaker

Journal of Arrhythmia, Volume 42, Issue 4, August 2026.
This study evaluated the impact of inferior vena cava (IVC) location, assessed by preoperative CT, on leadless pacemaker implantation in 96 patients. Left‐sided IVC group was significantly associated with a higher risk of multiple deployments compared to Right‐sided IVC group (67% vs. 36%, p = 0.02).
Tomoya Kimura, Yusuke Yoshikawa, Mari Nezu, Fumihiro Sakakibara, Takahiro Iseda, Takanari Fujita, Shuhei Tsuji, Satoshi Shizuta, Takeshi Morimoto   +8 more
wiley   +1 more source

Expanding Indications of Transcatheter Heart Valve Interventions. [PDF]

, 2015
Transcatheter aortic valve replacement (TAVR) has been established as a less invasive alternative to open-heart surgery in inoperable or high-risk patients presenting with symptomatic severe aortic valve stenosis. The feasibility and efficacy of valve-in-
Windecker, Stephan, Huber, Christoph, Carrel, Thierry, Praz, Fabien, Wenaweser, Peter Martin, Wenaweser, Peter   +5 more
core   +2 more sources